Literature DB >> 20838852

Aberrant signaling pathways in meningiomas.

Brian T Ragel1, Randy L Jensen.   

Abstract

In this article, we provide a brief description of the current understanding of aberrant signaling pathways in meningiomas. Cell signaling pathways are responsible for cellular differentiation, development, growth, growth inhibition, and death. In fact, signaling pathways can affect multiple intracellular functions, including those responsible for development, angiogenesis, and apoptosis. Ultimately, a further understanding of the signaling pathways involved in meningioma tumorigenesis will lead to the development and application of novel molecular treatments, such as small molecule inhibitors or interfering ribonucleic acid technologies.

Entities:  

Mesh:

Year:  2010        PMID: 20838852     DOI: 10.1007/s11060-010-0381-8

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  79 in total

1.  Expression and activation of epidermal growth factor receptors in meningiomas.

Authors:  R S Carroll; P M Black; J Zhang; M Kirsch; I Percec; N Lau; A Guha
Journal:  J Neurosurg       Date:  1997-08       Impact factor: 5.115

Review 2.  Molecular genetics of meningiomas.

Authors:  Brian T Ragel; Randy L Jensen
Journal:  Neurosurg Focus       Date:  2005-11-15       Impact factor: 4.047

3.  Celecoxib inhibits meningioma tumor growth in a mouse xenograft model.

Authors:  Brian T Ragel; Randy L Jensen; David L Gillespie; Stephen M Prescott; William T Couldwell
Journal:  Cancer       Date:  2007-02-01       Impact factor: 6.860

4.  The protein 4.1 tumor suppressor, DAL-1, impairs cell motility, but regulates proliferation in a cell-type-specific fashion.

Authors:  D H Gutmann; A C Hirbe; Z Y Huang ; C A Haipek
Journal:  Neurobiol Dis       Date:  2001-04       Impact factor: 5.996

5.  Gene expression profiling of the hedgehog signaling pathway in human meningiomas.

Authors:  Ingrid Laurendeau; Marcela Ferrer; Delia Garrido; Nicky D'Haene; Patricia Ciavarelli; Armando Basso; Michel Vidaud; Ivan Bieche; Isabelle Salmon; Irene Szijan
Journal:  Mol Med       Date:  2010-03-26       Impact factor: 6.354

6.  Different activation of mitogen-activated protein kinase and Akt signaling is associated with aggressive phenotype of human meningiomas.

Authors:  Christian Mawrin; Tina Sasse; Elmar Kirches; Siegfried Kropf; Thomas Schneider; Christoph Grimm; Claudia Pambor; Christian K Vorwerk; Raimund Firsching; Uwe Lendeckel; Knut Dietzmann
Journal:  Clin Cancer Res       Date:  2005-06-01       Impact factor: 12.531

7.  Expression of hypoxia inducible factor-1 alpha and correlation with preoperative embolization of meningiomas.

Authors:  Randy L Jensen; Scott Soleau; Mihir K Bhayani; Dustin Christiansen
Journal:  J Neurosurg       Date:  2002-09       Impact factor: 5.115

8.  Evidence for phosphatidylinositol 3-kinase-Akt-p7S6K pathway activation and transduction of mitogenic signals by platelet-derived growth factor in meningioma cells.

Authors:  Mahlon D Johnson; Evelyn Okedli; Ann Woodard; Steven A Toms; George S Allen
Journal:  J Neurosurg       Date:  2002-09       Impact factor: 5.115

9.  Protein 4.1B/differentially expressed in adenocarcinoma of the lung-1 functions as a growth suppressor in meningioma cells by activating Rac1-dependent c-Jun-NH(2)-kinase signaling.

Authors:  Mark A Gerber; Scott M Bahr; David H Gutmann
Journal:  Cancer Res       Date:  2006-05-15       Impact factor: 12.701

10.  ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons.

Authors:  S Tsukita; K Oishi; N Sato; J Sagara; A Kawai; S Tsukita
Journal:  J Cell Biol       Date:  1994-07       Impact factor: 10.539

View more
  19 in total

1.  Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma.

Authors:  David A Reardon; Andrew D Norden; Annick Desjardins; James J Vredenburgh; James E Herndon; April Coan; John H Sampson; Sridharan Gururangan; Katherine B Peters; Roger E McLendon; Julie A Norfleet; Eric S Lipp; Jan Drappatz; Patrick Y Wen; Henry S Friedman
Journal:  J Neurooncol       Date:  2011-09-22       Impact factor: 4.130

2.  Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series.

Authors:  Emil Lou; Ashley L Sumrall; Scott Turner; Katherine B Peters; Annick Desjardins; James J Vredenburgh; Roger E McLendon; James E Herndon; Frances McSherry; Julie Norfleet; Henry S Friedman; David A Reardon
Journal:  J Neurooncol       Date:  2012-04-26       Impact factor: 4.130

3.  Identification of epithelial membrane protein 2 (EMP2) as a molecular marker and correlate for angiogenesis in meningioma.

Authors:  Kunal S Patel; Sameer Kejriwal; Michel M Sun; Samasuk Thammachantha; Courtney Duong; Ann Chan; Nina Cherian; Prasanth Romiyo; Lynn K Gordon; William Yong; Madhuri Wadehra; Isaac Yang
Journal:  J Neurooncol       Date:  2020-01-24       Impact factor: 4.130

4.  Genomic analysis of synchronous intracranial meningiomas with different histological grades.

Authors:  Tamrin Chowdhury; Yongjin Yoo; Youngbeom Seo; Yun-Sik Dho; Sojin Kim; Anna Choi; Murim Choi; Sung-Hye Park; Chul-Kee Park; Sang Hyung Lee; Ji Yeoun Lee
Journal:  J Neurooncol       Date:  2018-02-08       Impact factor: 4.130

Review 5.  Pediatric meningioma: current approaches and future direction.

Authors:  Rishi S Kotecha; Reimar C Junckerstorff; Sharon Lee; Catherine H Cole; Nicholas G Gottardo
Journal:  J Neurooncol       Date:  2011-01-04       Impact factor: 4.130

6.  A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomas.

Authors:  Jeffrey J Raizer; Sean A Grimm; Alfred Rademaker; James P Chandler; Kenji Muro; Irene Helenowski; Laurie Rice; Katie McCarthy; Sandra K Johnston; Maciej M Mrugala; Marc Chamberlain
Journal:  J Neurooncol       Date:  2014-01-22       Impact factor: 4.130

7.  Posttranscriptional deregulation of signaling pathways in meningioma subtypes by differential expression of miRNAs.

Authors:  Nicole Ludwig; Yoo-Jin Kim; Sabine C Mueller; Christina Backes; Tamara V Werner; Valentina Galata; Elke Sartorius; Rainer M Bohle; Andreas Keller; Eckart Meese
Journal:  Neuro Oncol       Date:  2015-02-13       Impact factor: 12.300

8.  Alterations of oxidative phosphorylation in meningiomas and peripheral nerve sheath tumors.

Authors:  René G Feichtinger; Serge Weis; Johannes A Mayr; Franz A Zimmermann; Barbara Bogner; Wolfgang Sperl; Barbara Kofler
Journal:  Neuro Oncol       Date:  2015-06-23       Impact factor: 12.300

9.  Isolation and characterization of tumor stem-like cells from human meningiomas.

Authors:  Dueng-Yuan Hueng; Huey-Kang Sytwu; Shih-Ming Huang; Chen Chang; Hsin-I Ma
Journal:  J Neurooncol       Date:  2010-11-30       Impact factor: 4.130

Review 10.  Medical management of meningiomas.

Authors:  Wendy J Sherman; Jeff J Raizer
Journal:  CNS Oncol       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.